Navigation Links
GeneChoice RNA Safe Recombinant Ribonuclease Inhibitor from GeneChoice, Inc.

ProductsGeneChoice RNA Safe Recombinant Ribonuclease Inhibitor from GeneChoice, Inc.
Company GeneChoice, Inc.
Item GeneChoice RNA Safe Recombinant Ribonuclease Inhibitor
Price $142.00
Description Ribonuclease Inhibitor is a recombinant protein that has been shown to help maintain the integrity of RNA in the preparation of cDNA by reverse transcription, in vitro RNA transcription, and in vitro protein synthesis. RNA Safe Inhibitor tightly binds RNases in a 1:1 ratio. It inhibits a broad range of eukaryotic RNases such as RNase A, RNase B, RNase C, and human placental RNase. RNA Safe does not interfere with the performance of other enzymes in the reaction. • RNA Safe is most effective between pH 5.5 and 8.0. It does not inhibit AMV or MMLV reverse transcriptases; SP6, T3, and T7 RNA polymerases; Taq DNA polymerase; RNase H; RNase T1; or S1 Nuclease. • Efficient inhibition of ribonucleases •Protects RNA during cDNA synthesis and in vitro transcription/translation.

  • Applications: First and second strand cDNA synthesis, RT-PCR, and in vitro transcription and translation.
  • Unit Definition: One unit of protein inhibits the activity of 5 ng RNase A by 50%.
  • Enzyme Concentration: 40 to 50 units/µl.
  • Supplied As: 5,000 units.
  • Storage Conditions: Store at -20°C.
Info GeneChoice, Inc.GeneChoice, Inc.
7307 Governors Way
Frederick, MD 21703 USA

Call GeneChoice, Inc. to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-772-8354
Customer Service: 866-636-2200
Fax Number: 301-620-0162
Web Site: http://www.genechoiceinc.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. GeneChoice Taq DNA Polymerase With Standard Buffer from GeneChoice, Inc.
2. GeneChoice Taq DNA Polymerase With Ammonium Buffer from GeneChoice, Inc.
3. GeneChoice Taq DNA Polymerase With Magnesium Free Standard Buffer from GeneChoice, Inc.
4. GeneChoice TEMPase II DNA Polymerase from GeneChoice, Inc.
5. Recombinant Expression of Peptides and Proteins: from rPeptide, LLC
6. Recombinant RNasin® Ribonuclease Inhibitor from Promega
7. RNaseOUT Recombinant Ribonuclease Inhibitor from Invitrogen
8. hKv4.2/hKChIP2-CHO K1 Recombinant Cell Line from Upstate
9. hERG-CHO K1 Recombinant Cell Line from Upstate
10. hERG-CHO K1 Recombinant Cell Line from Upstate
11. hHCN4-CHO K1 Recombinant Cell Line from Upstate
Mouse Anti-Human MOC31 Monoclonal Antibody, Unconjugated from AbD Serotec
Goat Anti-Human LAIR2 Polyclonal Antibodies, Biotin Conjugated from R&D Systems
Incomplete Adjuvant from Santa Cruz Biotechnology, Inc.
...acks the mycobacteria found in Complete Freund's A... reason, Incomplete, Freund's Adjuvant is used ...e used to produce water-in-oil emulsions of immuno...te high and long-lasting antibody responses which ...
Biology Products:
(Date:11/4/2009)...wswire/ -- GenVault Corporation (Carlsbad, CA) tod...joined its Board of Directors. Dr. Brody, the Irw..., is an acclaimed physician-scientist and universi...r. Brody served as president of The Johns Hopkins ...y of Engineering and the Institute of Medicine, an...
(Date:11/3/2009)...e loner of the ocean, cruising thousands of miles ...discovered that the sharks have maintained such a ...thousands of years the white sharks in the northea... a population genetically distinct from sharks els..., highly mobile species," said Salvador Jorgensen,...
(Date:11/3/2009)...Chief executives in 35 of the top Fortune 500 comp...l salaries" in 2008, according to a new type of th... researcher to determine fair CEO compensation. ,... governance issues of the day is how to determine ...bramanian, a professor of chemical engineering. "T...
Breaking Biology News(10 mins):Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 2Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 3Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 4New theory on fairness in economics targets CEO pay 2New theory on fairness in economics targets CEO pay 3New theory on fairness in economics targets CEO pay 4Renal Physicians Association Participates in PEAK Campaign 50406 1Accumetrics Inc Announces GRAVITAS Trial 50 Percent Enrolled 4670 1Accumetrics Inc Announces GRAVITAS Trial 50 Percent Enrolled 4670 2First Book Focusing on How 26quot 3BThe Secret Pain Women Won 26apos 3Bt Talk About 26quot 3B Affects Relationships 50404 1First Book Focusing on How 26quot 3BThe Secret Pain Women Won 26apos 3Bt Talk About 26quot 3B Affects Relationships 50404 2First Book Focusing on How 26quot 3BThe Secret Pain Women Won 26apos 3Bt Talk About 26quot 3B Affects Relationships 50404 3First Book Focusing on How 26quot 3BThe Secret Pain Women Won 26apos 3Bt Talk About 26quot 3B Affects Relationships 50404 4
... Department of Energys Office of Science today rel...publication, Facilities for the Future of Science:...made significant progress in deploying the scienti...tes needs to capture world scientific leadership, ...partments missions. , When it was published four ...
...One of the World,s Leading Software ..., Oct. 10 (OTC Bulletin,Board: CICI) Communicatio...lier of electronic signature solutions for busines... the recognized leader in biometric signature,veri...rd time in Software,Magazine,s Software 500 rankin...
...angladesh finds that folic acid supplements can dr...ls chronically exposed to arsenic-contaminated dri...aturally present in some soils and water. Arsenic...icant public health problem in at least 70 countri...o parts of the United States. Chronic arsenic exp...
Other Biology News:DOE publishes update of plan: 'Facilities for the Future of Science: A 20-Year Outlook' 2DOE publishes update of plan: 'Facilities for the Future of Science: A 20-Year Outlook' 3DOE publishes update of plan: 'Facilities for the Future of Science: A 20-Year Outlook' 4DOE publishes update of plan: 'Facilities for the Future of Science: A 20-Year Outlook' 5CIC Again Named to Software Magazine's Annual Prestigious Software 500 List 2CIC Again Named to Software Magazine's Annual Prestigious Software 500 List 3Folic acid lowers blood arsenic levels in Bangladesh 2Folic acid lowers blood arsenic levels in Bangladesh 3
(Date:11/5/2009)...nce Call on Thursday, November 5, 2009 at 4:30 p.m...v. 5 /PRNewswire-FirstCall/ - OncoGenex Pharmaceut...: OGXI ) today reported unaudited financial resul...tember 30, 2009 and reviewed the Company,s highlig...wing consolidated results reflect the operations o...
(Date:11/5/2009)...LE, Calif., Nov. 5 Cephe...tives will be speaking at the following investor c...ia webcast. , , Credit Suisse Heal...ursday, 12 November, 2009 at 10 a.m. Mountain Time...m, London, England, Tuesday, 1 Dec...
(Date:11/5/2009)..., Calif., Nov. 5 WaferGe...eading developer of state-of-the-art genetic analy...s, Ph.D. has joined the company,s Scientific Advis...ng and commercializing novel molecular diagnostics...on the development of computational biology system...
(Date:11/5/2009)... Drug safety specialty firm BioSoteria...d Informatics earned the Certified Professional in... from the American Society for Training and Develo...ewell has more than fifteen years of medical commu...is responsible for the development of the company,...
Breaking Biology Technology:OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8Cepheid to Webcast Upcoming Financial Presentations 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 2BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 3BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 4